PDLIM2 and prostate adenocarcinoma: Univariate Cox analysis (HR = 1.856, 95% CI: 1.223-2.816, and P = 0.004) and multivariate Cox analysis (HR = 2.127, 95% CI: 1.375-4.291, and P < 0.001) indicated that PDLIM2 was a risk prognostic factor for PFI, while PDLIM6 (HR < 1, P < 0.05) was identified as a favorable prognostic factors in PRAD patients (Figure 2(c)).